Skip to main content
Clinical Trials/CTRI/2022/11/047236
CTRI/2022/11/047236
Not yet recruiting
Phase 3

Injectable-platelet rich fibrin (i-prf) as an adjunct to open flap debridement (ofd) in the management of periodontal osseous defects not indicated for regenerative therapy :a randomized controlled clinical trial

Dr Keerthana Varma KC0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Keerthana Varma KC
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Keerthana Varma KC

Eligibility Criteria

Inclusion Criteria

  • 1\)Adults above 18years diagnosed with periodontitis (according to AAP,2017 classification)
  • with residual probing pocket depth (PPD) \>\= 5 mm after step 1 and 2 therapy (non surgical
  • phase) in at least two adjacent interproximal sites in either of the jaws
  • 2\) Systemically healthy subjects
  • 3\) Deep pockets associated with horizontal bone defects that are not indicated for regenerative
  • 4\) Full Mouth Bleeding Score \<\= 30 % \& Full Mouth Plaque Score \<\= 20%

Exclusion Criteria

  • 1\) Current tobacco users
  • 2\) Subjects taking medications affecting the periodontium (Bisphosphonates ,Calcium channel
  • blockers ,cyclosporine ,phenytoin, steroids)
  • 3\) Pregnancy or lactation
  • 4\) Antibiotic medication in the last 3 months
  • 5\) Grade II/III furcation involvement
  • 6\) Infra bony defects that are indicated for resective or regenerative therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials